stockrowJourney Medical Corporation (DERM) vs Organigram Global Inc. (OGI)
- Journey Medical Corporation DERM 4.37 +1.63%
- Organigram Global Inc. OGI 0.88 −5.38%
Journey Medical Corporation and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation and Organigram Global Inc. are of similar size ($131.1M and $121.4M). Journey Medical Corporation has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 20.9%. Organigram Global Inc. has the higher net margin (28.4% vs −8.95%) and the higher return on invested capital (−1.53% vs −5.89%). Across the 19 metrics below, Organigram Global Inc. leads on 18 and Journey Medical Corporation on 1.
Valuation
Profitability
| Metric | DERM | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.45% | 36.47% | 53.51% |
| Operating margin | (4.41%) | (3.91%) | 0.00% |
| Net margin | (8.95%) | 28.44% | (2.45%) |
| Free cash flow margin | (10.99%) | (9.46%) | 0.00% |
| Return on equity | (23.77%) | 20.20% | (0.80%) |
| Return on assets | (6.80%) | 12.70% | (1.67%) |
| Return on invested capital | (5.89%) | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack